Buscar resultados de ensayos clínicos
Carcinoma, Transitional Cell - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy Condición: Urothelial Carcinoma Fecha: 2011-08-31 Intervenciones:
|
Completed |
Nombre del estudio: Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel Condición: Transitional Cell Carcinoma Fecha: 2012-08-13 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma Condición: Urinary Tract Urothelial Carcinoma Fecha: 2008-11-20 Intervenciones: Drug: Sunitinib Patients are treated with a 6-week inducti |
Active, not recruiting |
Nombre del estudio: DNA Methylation and Urothelial Carcinoma Condición: Urothelial Carcinoma Fecha: 2011-06-20 |
Active, not recruiting |
Nombre del estudio: EGCG Modulate the Cytotoxic Effects of Chemotherapeutic Agents in Human Urothelial Carcinoma Cells Condición: Urothelial Carcinoma Fecha: 2013-10-24 |
Active, not recruiting |
Nombre del estudio: The Role of Pyruvate Kinase M2 in Growth, Invasion and Drug Resistance in Human Urothelial Carcinoma Condición: Bladder Urothelial Carcinoma Fecha: 2013-10-21 |
Completed |
Nombre del estudio: DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma Condición: Urothelial Carcinoma Fecha: 2011-05-04 Intervenciones:
|
Completed |
Nombre del estudio: Arsenic Methylation Enzymes, Cigarette Metabolites, DNA Repair Enzymes, Inflammatory Factors and Urothelial Carcinoma Condición: Urothelial Carcinoma Fecha: 2009-03-01 |
Active, not recruiting |
Nombre del estudio: Neoadjuvant Erlotinib (Tarceva) in Transitional Cell Carcinoma Condición: Transitional Cell Carcinoma Fecha: 2008-09-05 Intervenciones: Drug: Erlotinib Hydrochloride 150 mg (pill) by mouth daily for 3 to 5 weeks prior to surgery |
Recruiting |
Nombre del estudio: Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma Condición: Urothelial Carcinoma Fecha: 2016-06-17 Intervenciones:
|